All News

After shooting himself in the finger during target practice in his backyard, a 37-year-old man presented with a traumatic injury to the left second digit. The patient said he was looking through the scope at the target when he released the trigger. However, he failed to realize that his finger was still at the base of the barrel of his 22-caliber pistol. He reported no significant medical history, routine medication use, or drug allergies, and denied smoking. The patient, a social drinker, admitted to having 2 to 3 beers that day.

BOSTON -- The brain of babies who die of sudden infant death syndrome (SIDS) have multiple serotonin system defects, and this appears to pin down an underlying fatal susceptibility in these children, according to researchers here.

LAS VEGAS -- Pill-sized cameras, self-navigating endoscopes, and other high-tech gadgetry may one day supplant or augment colonoscopy for colon cancer detection, according to a technology review presented here.

LAS VEGAS -- For treating patients with chronic constipation, a recently approved chloride channel activator compares well with other medications in efficacy and tolerability, according to a review of published data presented here.

LAS VEGAS -- Drugs that activate cannabinoid receptors in the colon might help treat lower GI conditions such as diarrhea or certain types of fecal incontinence, according to a proof-of-concept study presented here.

TUCSON, Ariz. -- Joints affected by the inflammation of rheumatoid arthritis may be soothed by dietary supplements containing extracts of the curry ingredient turmeric, researchers here studying rats reported.

SALT LAKE CITY -- For eight years a toy vampire's tooth was lodged invisibly in a man's lung, an unwelcome souvenir of a long-ago Halloween party, before a pulmonologist's persistence, trying to solve a mysterious cough, brought the object to light.

WASHINGTON -- Infusion of bone marrow-derived progenitor cells directly into a coronary infarct reduced by about half the risk of death, MI, or another revascularization procedure at 12 months, compared with patients getting sham infusions.

BOSTON -- For patients with the potentially fatal mucocutaneous blistering disease pemphigus vulgaris, a combination of Rituxan (rituximab) and intravenous immune globulin may succeed where other therapies have failed.